[ACRX] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
11-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -10.41%
YoY- -16.46%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 738 1,368 2,924 386 475 608 941 -14.89%
PBT -8,918 -8,930 -6,602 -15,925 -14,423 -12,731 -12,409 -19.68%
Tax 698 931 4 843 885 1,212 3 3620.92%
NP -8,918 -8,930 -6,606 -15,925 -14,423 -12,731 -12,412 -19.69%
Tax Rate - - - - - - - -
Total Cost 9,656 10,298 9,530 16,311 14,898 13,339 13,353 -19.35%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -1,208.40 -652.78 -225.92 -4,125.65 -3,036.42 -2,093.91 -1,319.02 -5.64%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -1.93 -2.03 -1.64 -3.98 -3.63 -3.20 -3.15 -27.75%
EPS Diluted -1.93 -2.03 -1.64 -3.98 -3.63 -3.20 -3.15 -27.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.